Y-mAbs

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Y-mAbs and other ETFs, options, and stocks.

About YMAB

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. 

CEO
Thomas Gad
CEOThomas Gad
Employees
148
Employees148
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2015
Founded2015
Employees
148
Employees148

YMAB Key Statistics

Market cap
196.21M
Market cap196.21M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
462.34K
Average volume462.34K
High today
$4.50
High today$4.50
Low today
$4.20
Low today$4.20
Open price
$4.28
Open price$4.28
Volume
442.33K
Volume442.33K
52 Week high
$20.48
52 Week high$20.48
52 Week low
$2.94
52 Week low$2.94

YMAB News

Yahoo Finance 14h
Y-mAbs to Host Annual Research and Development Day in New York - Yahoo Finance

Y-mAbs Therapeutics, Inc NEW YORK, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage bi...

Y-mAbs to Host Annual Research and Development Day in New York - Yahoo Finance
Yahoo Finance 5d
Y-mAbs Announces Complete Response Letter for Omburtamab Biologics License Application - Yahoo Finance

Y-mAbs Therapeutics, Inc NEW YORK, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage bi...

Y-mAbs Announces Complete Response Letter for Omburtamab Biologics License Application - Yahoo Finance

Analyst ratings

60%

of 10 ratings
Buy
60%
Hold
30%
Sell
10%

YMAB Earnings

-$0.94
-$0.38
$0.19
$0.75
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 23, After Hours
ActualExpected Feb 23, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.